Company intelligence / Profile preview

Farmak

Ownership: Public · FARM
Employees: ~3000
Development stage: Commercial

Overview

Farmak is Ukraine's pharmaceutical market leader with over 400 medicinal products across 14 therapeutic groups. The company exports to more than 50 countries and has expanded its international presence through acquisitions in Poland, Czech Republic, and Slovakia.

Therapeutic areas: GastroenterologyCardiovascularPsychiatryEndocrinologyWomen's HealthNeurologyInfectious Diseases
Modalities: Small moleculesgenericsspecialty generics
Industry: Biotech

Partnerships

Eli Lilly (for insulin production)European Bank for Reconstruction and Development (EBRD)

Financials

Market cap: $28.1M
Total revenue: $88.9M
Enterprise value: $98.8M

Beyond the preview

Go deeper on Farmak.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Farmak.

Explore the full profile